Your browser does not support javascript:   Search for gard hereSearch for news-and-events here.

Diseases

Genetic and Rare Diseases Information Center (GARD)

Print friendly version

Precocious puberty


Other Names for this Disease

  • Familial precocious puberty
  • Idiopathic sexual precocity
  • Sexual precocity
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.

Treatment

Clinical Trials & Research for this Disease

  • ClinicalTrials.gov lists trials that are studying or have studied Precocious puberty. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies.

Medical Products

The medication(s) listed in the table(s) below have been approved by the Food and Drug Administration (FDA) for treatment of this condition. The FDA Office of Orphan Products Development designates "orphan products" for those that treat rare diseases affecting fewer than 200,000 Americans. The table(s) below may not be an exhaustive list of drugs or products used to treat this condition. There may be other products available that are not considered orphan products. To search for all FDA approved drugs, visit Drugs@FDA. You can find orphan products used to treat other conditions by searching the Orphan Drug Product Designation database.


Generic Name Leuprolide acetate
Trade Name
(Manufacturer Name)
Lupron (injection)
(Abbott)
Indication
The FDA has approved this product to be used in this manner.
Treatment of children with central precocious puberty.
More Information about this product Drug Information Portal
Medline Plus Health Information

Generic Name Histrelin acetate
Trade Name
(Manufacturer Name)
Supprelin LA (implant)
(Endo Pharmaceuticals)
Indication
The FDA has approved this product to be used in this manner.
Treatment of central precocious puberty.
More Information about this product Drug Information Portal

Generic Name Histrelin
Trade Name
(Manufacturer Name)
Supprelin® LA
(Endo Pharmaceuticals)
Indication
The FDA has approved this product to be used in this manner.
Treatment of central precocious puberty
More Information about this product Drug Information Portal

Generic Name Nafarelin acetate
Trade Name
(Manufacturer Name)
Synarel (nasal solution)
(Pfizer)
Indication
The FDA has approved this product to be used in this manner.
Treatment of central precocious puberty (gonadotropin-dependent precocious puberty) in children of both sexes.
More Information about this product Drug Information Portal
Medline Plus Health Information

Other Names for this Disease
  • Familial precocious puberty
  • Idiopathic sexual precocity
  • Sexual precocity
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.